UCB, a global biopharmaceutical company, and XtalPi, a global leader in AI drug discovery, today announced a license ...

New Jersey-based pharmaceutical company UCB has sued to protect its patents for a Parkinson’s drug after an India-based ...

Global Student Entrepreneurs Awards (GSEA) powered by Entrepreneurs’ Organization (EO) is the world’s largest annual award ...

Trading Advice for United Community Banks Inc. UCB including day trading swing trading and long term investing plans for UCB ...

Mark Bodmer and Jonathan Lewis of UCB pharma talk us though the partnering model at UCB, and how partnering can drive innovation. The world is changing and it’s no different for the ...

Belgian pharmaceutical company UCB is dropping its development of minzasolmin in patients with Parkinson's' disease after the ORCHESTRA study failed to meet its primary and secondary endpoints.

Researchers from UCB SA and affiliated organizations presented the discovery and preclinical characterization of novel NUAK family SnF1-like kinase-1 (NUAK1) inhibitors.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

A phase 3 trial of Biogen (NASDAQ:BIIB) and UCB's (OTCPK:UCBJF)(OTCPK:UCBJY) dapirolizumab pegol for systemic lupus erythematosus met its primary endpoint, demonstrating significant improvement in ...

HAWLEY – Six pins led the Park Rapids wrestling team to a 43-29 win against Roseau while forfeiting five matches enabled ...